EBMcalc Cardiac 23.3.1

EBMcalc Cardiac represents a highly regarded and extensive medical calculation platform that has been validated and reviewed over the past 25 years. As a comprehensive resource, it encompasses a wide range of pertinent equations, clinical criteria sets, decision tree tools, and dose/unit converters frequently utilized by cardiovascular specialists.

It's important for users to understand that the app's content should not replace professional medical advice; clinical decisions should always be made in consultation with a qualified healthcare provider.

The system includes critical equations such as the prediction of acute heart failure using NT-proBNP levels and clinical features; pediatric blood pressure percentiles aligned with the latest 2017 AAP guidelines; and calculations for cardiac output, DLCO corrected for anemia, and systemic vascular resistance, among others. It also features tools for assessing energy loss index in aortic stenosis, Friedewald LDL calculation, Gorlin formula for valve area, and various indices related to oxygenation and vascular pressures.

In terms of clinical criteria sets, EBMcalc covers established risk assessment models such as the ACC/AHA 2013 cardiovascular risk calculator, PROCAM, MESA, ReV cohort, Reynolds risk score, Framingham profiles, and multiple others. It also incorporates diagnostic criteria for conditions including atrial fibrillation, endocarditis, Kawasaki disease, Ehlers-Danlos syndrome type IV, and rheumatic fever.

Additional modules address postoperative risk assessments like EuroSCORE and GRACE scores, prediction models for myocardial infarction, stroke risk projections, thromboembolism risk in hospitalized patients (Padua Score), and bleeding risks associated with thrombolytic therapy. Tools for evaluating venous thromboembolism risk, systolic murmur significance, and ventriculogram interpretation are also included.

The decision trees integrated within the system facilitate diagnosis and management decisions for conditions such as aortic stenosis, inferior wall myocardial infarction, ventricular pacing issues, obesity management, perioperative assessment, smoking cessation strategies, lipid management pre-ATP III guidelines, and warfarin dosing protocols.

EBMcalc offers an accessible interface with interactive tools designed to support clinicians committed to evidence-based practice. Nonetheless, it remains essential to interpret its findings within the broader context of each patient’s clinical situation.